Plus Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.22-0.19-0.270.75
Price/Sales ratio
2.760.470.140.09
Earnings per Share (EPS)
$-2.30$-2.65$-1.86$0.68

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.36-1.42-1.18-0.42-0.19-0.26-0.95-0.88-0.40-0.41-0.36-0.26
Price/Sales ratio
6.722.292.291.510.840.4729.51N/A37.501.11N/A0.47
Price/Book Value ratio
-8.962.192.370.740.482.862.951.171.30-4.071.130.48
Price/Cash Flow ratio
-1.68-1.30-1.33-0.53-0.21-0.56-1.06-1.23-0.64-0.42-0.56-0.56
Price/Free Cash Flow ratio
-1.63-1.26-1.33-0.49-0.20-0.55-1.00-1.21-0.62-0.42-0.54-0.54
Price/Earnings Growth ratio
-0.560.020.030.000.000.000.010.020.010.00-0.010.00
Dividend Yield
N/A0.28%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
61.30%72.67%76.14%79.44%61.51%23.33%-791.08%N/A-217.85%-97.23%N/A23.33%
Operating Profit Margin
-426.91%-131.10%-173.16%-322.61%-293.73%-52.25%-3163.03%N/A-8800%-271.13%N/A-293.73%
Pretax Profit Margin
-491.81%-160.76%-193.72%-353.86%-297.61%-46.91%-2719.80%N/A-9051.33%-271.03%N/A-297.61%
Net Profit Margin
-491.81%-160.76%-193.72%-353.86%-423.53%-182.08%-3085.14%N/A-9302.67%-271.03%N/A-423.53%
Effective Tax Rate
-10.07%-18.92%-12.81%-9.08%-22.36%-288.12%-13.43%-6.95%-2.77%N/AN/A-22.36%
Return on Assets
-96.51%-49.72%-63.70%-71.75%-52.66%-54.85%-77.22%-65.19%-87.30%-116.93%-84.94%-54.85%
Return On Equity
655.34%-153.56%-200.67%-174.50%-241.79%-1098.44%-308.41%-132.25%-323.32%987.83%-192.31%-241.79%
Return on Capital Employed
-142.25%-52.24%-89.13%-156.67%-136.22%-41.82%-268.76%-77.53%-164.06%-2015.27%-117.68%-136.22%
Liquidity Ratios
Current Ratio
1.362.511.490.800.541.361.07N/AN/AN/A1.840.54
Quick Ratio
1.052.001.200.630.541.361.083.361.840.911.520.54
Cash ratio
0.911.691.000.510.291.210.973.131.520.791.520.29
Days of Sales Outstanding
65.3341.0739.838.2528.5060.9771.07N/AN/AN/AN/A60.97
Days of Inventory outstanding
599.51492.39500.78881.4834.027.27-7.97-38.71N/AN/AN/A7.27
Operating Cycle
664.85533.46540.61889.7362.5268.2563.09N/AN/AN/AN/A68.25
Days of Payables Outstanding
117.81115.59179.07359.18229.2322.24106.6614.43K4.28K179.22N/A22.24
Cash Conversion Cycle
547.03417.87361.54530.55-166.7046.00-43.56N/A-4.28K-179.22N/A-166.70
Debt Ratios
Debt Ratio
0.650.440.500.430.590.470.520.300.230.340.720.59
Debt Equity Ratio
-4.451.361.601.042.719.532.090.620.85-2.942.709.53
Long-term Debt to Capitalization
1.460.570.50N/AN/AN/AN/A0.310.37N/A0.02N/A
Total Debt to Capitalization
1.280.570.610.510.730.900.670.380.461.510.220.90
Interest Coverage Ratio
-7.50-6.79-7.60-10.09-6.60-1.97-7.95N/AN/AN/A-19.88-1.97
Cash Flow to Debt Ratio
-1.19-1.22-1.10-1.33-0.84-0.53-1.33-1.52-2.35-3.23-6.97-0.53
Company Equity Multiplier
-6.793.083.152.434.5920.023.992.023.70-8.443.7020.02
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-3.99-1.75-1.71-2.82-4.01-0.84-27.83N/A-57.91-2.61N/A-4.01
Free Cash Flow / Operating Cash Flow Ratio
1.031.031.001.081.011.011.051.011.031.011.031.01
Cash Flow Coverage Ratio
-1.19-1.22-1.10-1.33-0.84-0.53-1.33-1.52-2.35-3.23-6.97-0.53
Short Term Coverage Ratio
-4.11N/A-2.94-1.33-0.84-0.53-1.33-5.98-7.55-3.23-7.55-0.53
Dividend Payout Ratio
N/A-0.40%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A